RSS Feeds
Search

Press releases

Press releases

Displaying 1..2 of 2 - per page
Order by
Labtec´s sufentanil patch for chronic pain enters phase II in cooperation with hameln rds GmbH
Labtec GmbH, Langenfeld, Germany announces the start of the phase II clinical development program for its sufentanil transdermal patch. More
HELM AG Acquires Shares in Amarin Technologies S.A.
Hamburg, December 10th, 2010

Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development company in Buenos Aires, Argentina.

Amarin h More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Drug Delivery Markets, Vol. IV: Transdermal and Trans Mucosal Drug Delivery
Apr 2007 - 118 pages - $2,495
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV)
Jun 2009 - 118 pages - $1,040
Who's Developing What in Drug Delivery 2009
Nov 2009 - 830 pages - $1,040
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
Jun 2009 - 110 pages - $1,040
Drug Delivery: Global Industry Guide
Dec 2006 - 90 pages - $995
Drug Delivery Technologies: Players, products & prospects to 2018
Jun 2009 - 472 pages - $3,140
Leading Drug Delivery Companies and Technologies
Jun 2008 - 175 pages - $3,835
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech
Nov 2010 - 428 pages - $2,695
Topical OTC Medicines Market in the US to 2014 (OTC Healthcare)
Mar 2011 - 24 pages - $350
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us